Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery (Q33955046)

30 July 2017

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery (English)

1 reference

30 July 2017

0 references

10

0 references

author name string

P Calvo

1

1 reference

30 July 2017

B Gouritin

2

1 reference

30 July 2017

H Chacun

3

1 reference

30 July 2017

D Desmaële

4

1 reference

30 July 2017

J D'Angelo

5

1 reference

30 July 2017

J P Noel

6

1 reference

30 July 2017

D Georgin

7

1 reference

30 July 2017

E Fattal

8

1 reference

30 July 2017

J P Andreux

9

1 reference

30 July 2017

1 August 2001

1 reference

30 July 2017

Pharmaceutical Research

1 reference

30 July 2017

18

1 reference

30 July 2017

8

1 reference

30 July 2017

1157-1166

1 reference

Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism

30 July 2017

1 reference

12 December 2020

Vector-mediated drug delivery to the brain

1 reference

12 December 2020

Brain drug delivery of small molecules using immunoliposomes

1 reference

12 December 2020

Liposome targeting to mouse brain: mannose as a recognition marker

1 reference

12 December 2020

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

1 reference

12 December 2020

Near infrared with principal component analysis as a novel analytical approach for nanoparticle technology

1 reference

12 December 2020

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

1 reference

12 December 2020

Quantitative aspects of reversible osmotic opening of the blood-brain barrier

1 reference

12 December 2020

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

1 reference

12 December 2020

The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system

1 reference

12 December 2020

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

1 reference

12 December 2020

Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat

1 reference

12 December 2020

Spleen capture of nanoparticles: influence of animal species and surface characteristics

1 reference

12 December 2020

Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections.

1 reference

12 December 2020

In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres.

1 reference

12 December 2020

Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum

1 reference

12 December 2020

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

1 reference

12 December 2020

Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.

1 reference

12 December 2020

Biodegradable long-circulating polymeric nanospheres

1 reference

12 December 2020

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

1 reference

12 December 2020

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

1 reference

12 December 2020

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

1 reference

12 December 2020

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1010931127745

1 reference

30 July 2017

1 reference